This inventor holds 1 USPTO granted patent. Top assignee: Veb Fahlberg-List Chemische Und Pharmazeutische Fabriken. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Lothar Lucke: Innovator in Pharmaceutical Preparations
Introduction
Lothar Lucke is a notable inventor based in Magdeburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of active ingredients in drug formulations. His innovative approach has the potential to improve the effectiveness of oral medications.
Latest Patents
Lucke holds a patent for a composition and methods aimed at providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (HMLO). This patent focuses on improving the absorption of HMLO by incorporating bile acids into the pharmaceutical preparation. The use of bile acids, such as desoxycholic acid or dehydrocholic acid, significantly enhances the drug's effectiveness when administered orally.
Career Highlights
Lothar Lucke has been associated with Veb Fahlberg-List Chemische Und Pharmazeutische Fabriken, where he has applied his expertise in pharmaceutical sciences. His work has contributed to advancements in drug formulation and delivery systems, making a positive impact on patient care.
Collaborations
Throughout his career, Lucke has collaborated with esteemed colleagues, including Reinhard Neubert and Jurgen Slapke. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Lothar Lucke's contributions to pharmaceutical innovations demonstrate his commitment to improving drug efficacy and patient outcomes. His work continues to influence the field, paving the way for future advancements in medication delivery systems.